Management Board meeting: 16-17 March 2022
Table of contents
Date:
16/03/2022 to 17/03/2022
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
-
List item
Agenda for the 115th meeting of the Management Board: 16-17 March 2022 (PDF/163.29 KB)
Adopted
First published: 16/03/2022
Last updated: 18/03/2022
EMA/MB/30014/2022 -
List item
Minutes of the 115th meeting of the Management Board: 16-17 March 2022 (PDF/440.04 KB)
Adopted
First published: 16/06/2022
EMA/MB/169135/2022 -
List item
OPEN Pilot: One-year review and recommendations (PDF/474.84 KB)
First published: 07/07/2022
EMA/6881/2022 -
List item
Outcome of written procedures finalised during the period from 25 November 2021 to 18 February 2022 (PDF/113.6 KB)
First published: 20/04/2022
EMA/MB/149565/2022 -
List item
Summary of transfers of appropriations in budgets 2021 and 2022 (PDF/106.84 KB)
First published: 20/04/2022
EMA/MB/58837/2022 -
List item
2021 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission (PDF/846.26 KB)
First published: 17/03/2022
EMA/719826/2021 -
List item
Minor uses and minor species (MUMS)/limited market scheme for veterinary medicinal products - 12th annual report (PDF/295.18 KB)
Adopted
First published: 18/03/2022
EMA/573681/2021 -
List item
2021 European Medicines Agency annual report on independence (PDF/374.41 KB)
Adopted
First published: 18/03/2022
EMA/759921/2021 -
List item
Superseded - Composition of the Emergency Task Force (ETF) for the therapeutic response to the COVID-19 pandemic (PDF/308.72 KB)
First published: 18/03/2022
Last updated: 08/11/2022
EMA/555794/2021